DOI QR코드

DOI QR Code

Differences in physical function, self-efficacy, and health-related quality of life by disease severity in community-dwelling patients with chronic obstructive pulmonary disease

  • Hee-Young, Song (Wonju College of Nursing, Yonsei University) ;
  • Kyoung A Nam (School of Nursing.Research Institute of Nursing Science, Hallym University)
  • Received : 2023.06.07
  • Accepted : 2023.08.11
  • Published : 2023.08.31

Abstract

Purpose: This study investigated the differences in physical function, self-efficacy (SE), and health-related quality of life (HRQoL) categorized by disease severity in community-dwelling patients with chronic obstructive pulmonary disease (COPD). Methods: This cross-sectional study included 182 patients with COPD selected from the pulmonology outpatient department of a tertiary hospital. Disease severity was measured using forced expiratory volume in 1 second (FEV1). Physical function, SE, and HRQoL were measured with the six-minute walking distance, Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE), and St. George's Respiratory Questionnaire (SGRQ). Disease duration, FEV1, and 12-month history of exacerbations were obtained from medical records. Patients were categorized by Global Initiative for Chronic Obstructive Lung Disease (GOLD) category. Data were analyzed using the χ2 test, and one-way ANOVA. Results: Most of the participants were male and nonsmokers. The disease duration was 10.76 ± 10.03 years, the mean FEV1% was 62.13 ± 22.80, and 70.3% of the participants were in GOLD category 2 (moderate) or milder. Half of the participants reported modified Medical Research Council scores ≥ 2. Patients in GOLD categories 1 and 3 (mild and severe) exhibited significantly higher PRAISE scores than those in the other groups (F = 8.23, p < .001). The total SGRQ scores were highest in GOLD 4 (very severe), indicating the lowest HRQoL. Significant differences were identified among GOLD 1, GOLD 2 and 3, and GOLD 4 (F = 9.92, p < .001). Conclusion: We identified potentially useful variables to comprehensively assess disease severity and tailor management strategies, including airflow limitation, and to determine the consequences of COPD from patients' perspectives.

Keywords

Acknowledgement

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF2016R1D1A1A09918871).

References

  1. Mok H, Jo KH. Association between physical activity and health-related quality of life in Korean patients with COPD. Journal of Korean Society for School & Community Health Education. 2019;20(1):15-27. https://doi.org/10.35133/kssche.20190430.02
  2. An TJ, Yoon HK. Prevalence and socioeconomic burden of chronic obstructive pulmonary disease. Journal of the Korean Medical Association. 2018;61(9):533-538. https://doi.org/10.5124/jkma.2018.61.9.533
  3. GOLD. 2022 Global strategy for prevention, diagnosis and management of COPD [Internet]. Global Initiative for Chronic Obstructive Lung Disease; 2021 [cited 2023 May 1]. Available from: https://goldcopd.org/archived-reports/
  4. Theander K, Jakobsson P, Jorgensen N, Unosson M. Effects of pulmonary rehabilitation on fatigue, functional status and health perceptions in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Clinical Rehabilitation. 2009;23(2):125-136. https://doi.org/10.1177/0269215508096174
  5. Korean Academy of Tuberculosis and Respiratory Diseases. 2018 Guidelines for COPD [Internet]. Seoul: Korean Academy of Tuberculosis and Respiratory Diseases; 2018 [cited 2023 May 1]. Available from: https://www.lungkorea.org/bbs/index.html?code=guide&category=&gubun=&page=1&number=8186&mode=view&keyfield=&key=
  6. Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, et al. An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 2015;192(11):1373-1386. https://doi.org/10.1164/rccm.201510-1966ST
  7. Kim DK, Rhee CK. Updated view on the treatment of chronic obstructive pulmonary disease in Korea. Journal of the Korean Medical Association. 2021;64(3):225-231. https://doi.org/10.5124/jkma.2021.64.3.225
  8. Tsiligianni I, Sifaki-Pistolla D, Gergianaki I, Kampouraki M, Papadokostakis P, Poulonirakis I, et al. Associations of sense of coherence and self-efficacy with health status and disease severity in COPD. NPJ Primary Care Respiratory Medicine. 2020;30(1):27. https://doi.org/10.1038/s41533-020-0183-1
  9. Lopes AC, Xavier RF, Pereira ACAC, Stelmach R, Fernandes FLA, Harrison SL, et al. Identifying COPD patients at risk for worse symptoms, HRQoL, and self-efficacy: a cluster analysis. Chronic Illness. 2019;15(2):138-148. https://doi.org/10.1177/1742395317753883
  10. Afroz N, Gutzwiller FS, Mackay AJ, Naujoks C, Patalano F, Kostikas K. Patient-Reported Outcomes (PROs) in COPD clinical trials: trends and gaps. International Journal of Chronic Obstructive Pulmonary Disease. 2020;15:1789-1800. https://doi.org/10.2147/COPD.S235845
  11. Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respiratory Research. 2017;18(1):67. https://doi.org/10.1186/s12931-017-0548-3
  12. Hurst JR, Siddiqui MK, Singh B, Varghese P, Holmgren U, de Nigris E. A systematic literature review of the humanistic burden of COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2021;16:1303-1314. https://doi.org/10.2147/COPD.S296696
  13. Chai CS, Ng DLC, Bt Mos S, Ibrahim MAB, Tan SB, Pang YK, et al. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 - a post-hoc analysis of pooled data. BMC Pulmonary Medicine. 2023;23(1):150. https://doi.org/10.1186/s12890-023-02436-1
  14. Irwin DE, Atwood CA, Hays RD, Spritzer K, Liu HH, Donohue JF, et al. Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations. Quality of Life Research. 2015;24(4):999-1009. https://doi.org/10.1007/s11136-014-0818-1
  15. Cohen J. Statistical power analysis for the behavior science. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associate; 1988.
  16. van Dijk WD, van den Bemt L, van den Haak-Rongen S, Bischoff E, van Weel C, Veen JC, et al. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respiratory Research. 2011;12(1):151. https://doi.org/10.1186/1465-9921-12-151
  17. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091-1097. https://doi.org/10.1378/chest.09-2029
  18. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586. https://doi.org/DOI10.1136/thx.54.7.581
  19. Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, Oh IJ, et al. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulmonary Medicine. 2013;13:35. https://doi.org/10.1186/1471-2466-13-35
  20. American Thoracic Society. Standardization of spirometry, 1994 update. American Journal of Respiratory and Critical Care Medicine. 1995;152(3):1107-1136. https://doi.org/10.1164/ajrccm.152.3.7663792
  21. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine. 2002;166(1):111-117. https://doi.org/10.1164/ajrccm.166.1.at1102
  22. Vincent E, Sewell L, Wagg K, Deacon S, Williams J, Singh S. Measuring a change in self-efficacy following pulmonary rehabilitation: an evaluation of the PRAISE tool. Chest. 2011;140(6):1534-1539. https://doi.org/10.1378/chest.10-2649
  23. Song HY, Nam KA. Psychometric properties of the Korean version of the Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) for individuals with COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2017;12:2611-2620. https://doi.org/10.2147/COPD.S142488
  24. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. American Review of Respiratory Disease. 1992;145(6):1321-1327. https://doi.org/10.1164/ajrccm/145.6.1321
  25. Kim YS, Byun MK, Jung WY, Jeong JH, Choi SB, Kang SM, et al. Validation of the Korean version of the St. George's Respiratory Questionnaire for patients with chronic respiratory disease. Tuberculosis and Respiratory Diseases. 2006;61(2):121-128. https://doi.org/10.4046/trd.2006.61.2.121
  26. Song HY, Yong SJ, Hur HK. Effectiveness of a brief self-care support intervention for pulmonary rehabilitation among the elderly patients with chronic obstructive pulmonary disease in Korea. Rehabilitation Nursing. 2014;39(3):147-156. https://doi.org/10.1002/rnj.92
  27. Shin YB. Pulmonary rehabilitation for patients with COPD and asthma. Annals of CardioPulmonary Rehabilitation. 2021;1(1):23-32. https://doi.org/10.53476/acpr.2021.1.1.23
  28. Kang GJ, Kim MH, Hwang SK. Self-care, symptom experience, and health-related quality of life by COPD severity. Journal of Korean Academy of Adult Nursing. 2008;20(1):163-175.
  29. Dignani L, Toccaceli A, Lucertini C, Petrucci C, Lancia L. Sleep and quality of life in people with COPD: a descriptive-correlational study. Clinical Nursing Research. 2016;25(4):432-447. https://doi.org/10.1177/1054773815588515
  30. Aldhahi MI, Baattaiah BA, Nazer RI, Albarrati A. Impact of psychological factors on functional performance among patients with chronic obstructive pulmonary disease. International Journal of Environmental Research and Public Health. 2023;20(2):1285. https://doi.org/10.3390/ijerph20021285